We are excited to report that Congress has funded the congressionally directed Department of Defense (DoD) funding for Fiscal Year 2018 (FY18) with $80 million to support innovative, high-impact cancer research. This is a major increase from last year’s $60 million, $50 million the year before, and $25 million two years prior. The upward trend, in particular, is very promising.
Mesothelioma is one of 17 cancers competing for this funding, thus the more money available overall means that more funding is available for quality mesothelioma research, too.
In 2008, this Foundation played a crucial role in this eligibility, arguing in front of the DoD that as a cancer affecting a high number of military personnel, and specifically Navy personnel, it fit perfectly within the program’s guidelines. The 2008 addition of mesothelioma has resulted in over $15 million directed to mesothelioma research to date.